Publications

  1. Marsh RA, Allen CE, Mcclain KL, Weinstein JL, Kanter J, Skiles J, Lee ND, Khan SP, Lawrence J, Mo JQ, Bleesing JJ, Filipovich AH, Jordan MB. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer. 2013; 60(1):101-9. 2290287
  2. Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012 Oct 18; 367(16):1487-96. 2285494
    View PubMed
  3. Khan S, Juckett MB, Komanduri KV, Krishnan A, Burns LJ, American Society of Blood and Marrow Transplantation Committee on Education. American Society of Blood and Marrow Transplantation Guidelines for Training in Hematopoietic Progenitor Cell Transplantation. Biol Blood Marrow Transplant. 2012 Sep; 18(9):1322-8. Epub 2012 Apr 19. 2243827
    View PubMed
  4. Nageswara Rao AA, Kumar R, Altaf S, Gourde JA, Rodriguez V, Khan SP. Pretransplant conditioning with Campath-1H (alemtuzumab) in pediatric matched unrelated hematopoietic stem cell transplants: an institutional experience. J Pediatr Hematol Oncol. 2012 Mar; 34(2):96-100. 2209894
    View PubMed
  5. Joshi A, Ham E, Shah N, Dong X, Khan S, Abraham R. Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency. Case Reports in Immunology. 2012; 2012. 2249397
  6. Kumar R, Galardy PJ, Dogan A, Rodriguez V, Khan SP. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma. Pediatr Blood Cancer. 2011 Aug; 57(2):317-20. Epub 2011 Apr 01. 2157386
    View PubMed
  7. Oliveira JL, Kumar R, Khan SP, Law ME, Erickson-Johnson M, Oliveira AM, Ketterling RP, Dogan A. Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion. Pediatr Blood Cancer. 2011 Mar; 56(3):467-9. Epub 2010 Nov 11. 2143279
    View PubMed
  8. Kumar R, Khan SP, Joshi DD, Shaw GR, Ketterling RP, Feldman AL. Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A. Pediatr Blood Cancer. 2011 Feb; 56(2):307-10. 2121132
    View PubMed
  9. Kumar R, Rodriguez V, Khan SP, Laack N, Arndt CA. Post Radiation Dermatofibrosarcoma Protuberans in a Patient with Wilms tumor. Journal of pediatric hematology Oncology. 2011. 2138105
  10. Horn B, Soni S, Khan S, Petrovic A, Breslin N, Cowan M, Pelle-Day G, Cooperstein E, Baxter-Lowe LA. Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies. Bone Marrow Transplant. 2009 Mar; 43(6):469-76. Epub 2008 Oct 27. 1905136
    View PubMed
  11. Renaud DL, Khan S. Development of a multidisciplinary programme for the treatment of X-linked adrenoleukodystrophy. Paediatr. Child Health (CAN) 2009; 19(Suppl 2):S217-9. 1983298
    View PubMed
  12. Sabapathy C, Gourde JA, Khan SP, Rodriguez V. Tacrolimus with mini-methotrexate as prophylaxis for graft-versus-host disease in pediatric patients after allogeneic peripheral blood stem cell transplant or bone marrow transplant. J Pediatr Hematol Oncol. 2008 Dec; 30(12):945-9. 1914859
    View PubMed
  13. Frangoul H, Nemecek ER, Billheimer D, Pulsipher MA, Khan S, Woolfrey A, Manes B, Cole C, Walters MC, Ayas M, Ravindranath Y, Levine JE, Grupp SA. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood. 2007 Dec 15; 110(13):4584-7 Epub 2007 Sep 7. 1888321
    View PubMed
  14. Rodriguez V, Anderson PM, Trotz BA, Arndt CA, Allen JA, Khan SP. Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut. Pediatr Blood Cancer. 2007 Aug; 49(2):212-5. 1834782
    View PubMed
  15. Kennedy-Nasser AA, Leung KS, Mahajan A, Weiss HL, Arce JA, Gottschalk S, Carrum G, Khan SP, Heslop HE, Brenner MK, Bollard CM, Krance RA. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant. 2006 Dec; 12(12):1277-84. 1804181
    View PubMed
  16. Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA, Territo MC, Collins RH, McSweeney PA, Copelan EA, Khan SP, Woolfrey A, Storer B. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood. 2006 Sep 1; 108(5):1485-91. Epub 2006 May 09. 1779707
    View PubMed
  17. Rodriguez V, Anderson PM, Litzow MR, Erlandson L, Trotz BA, Arndt CA, Khan SP, Wiseman GA. Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia. Leuk Lymphoma. 2006 Aug; 47(8):1583-92. 1782323
    View PubMed
  18. Imran H, Tleyjeh IM, Zirakzadeh A, Rodriguez V, Khan SP. Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. Bone Marrow Transplant. 2006 Apr; 37(7):677-86. 1754286
    View PubMed
  19. Rodriguez V, Khan SP. Late graft rejection following allogeneic bone marrow transplantation in aplastic anemia. Transplant Proc. 2002 Jun; 34(4):1307-9. 1316074
    View PubMed
  20. Rodriguez V, Kuehnle I, Heslop HE, Khan S, Krance RA. Guillain-Barre syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002 Mar; 29(6):515-7. 1315510
    View PubMed
  21. Mhawech P, Buffone GJ, Khan SP, Gresik MV. Cytochemical staining and flow cytometry methods Applied to the diagnosis of acute leukemia in the pediatric population: an assesment of relative usefulness. Journal of Pediatric Hematology/Oncology. 2001; 23(2):89-92. 1216434
  22. Deeg HJ, Amylon ID, Harris RE, Collins R, Beatty PG, Feig S, Ramsay N, Territo M, Khan SP, Pamphilon D, Leis JF, Burdach S, Anasetti C, Hackman R, Storer B, Mueller B. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Biol Blood Marrow Transplant. 2001; 7(4):208-15. 1979816
    View PubMed
  23. Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 2000; 11:1465-75. 1216433
    View PubMed
  24. Seber A, Khan SP, Kersey JH. Unexplained effusions: association with allogeneic BMT and acute or chronic GVHD. Bone marrow Transplantation. 1996; 17:207-11. 1216431
    View PubMed
  25. Davies SM, Khan SP, Wagner JE, Arthur DC, Auerbach AD, Ramsay NKC, Weisdorf DJ. Unrelated donor Bone marrow transplantation for fanconi anemia. Bone Marrow Transplantation. 1996; 17:43- 47. 1216432
    View PubMed
  26. Khan SP, Gilchrist GS, Arndt CA, Smithson WA, Chen MG, Schomberg PJ, Matsumoto JM, O'Fallon WM. Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. Mayo Clin Proc. 1994 Oct; 69(10):949-54. 88943
    View PubMed
  27. Khan SP, Raza A, Yousuf N, Barcos M, Saikia T, Masterson M, Bennett J, Browman G, Goldberg J, Grunwald H, Larson R, Sandberg A, Vogler R, Priesler HD. Cell cycle and clinical characteristics of patients with myeloproliferative disorders whose biopsies are reactive with anti-factor VIII antibody : a leukemia inter-group study. Leukemia Research. 1991; 15:51-7. 1216430
    View PubMed
  28. Raza A, Khan SP, Mehdi I, Imren S, Yasin Z, Priesler HD. Cell cycle characteristics in Myeloid leukemias. Bone Marrow Transplantation Vol 4 suppl. 1989; 1:26-9. 1216429
  29. Raza A, Maheshwari Y, Mandava N, Yasin Z, Perveen S, Mayers G, Goldberg J, Gottlieb A, Grunwald H, Larson R, Miller K, Vogler R, Priesler HD. Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemia. Sem Oncol 14 Suppl. 1987; 1:217-25. 1216428